FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Human Drugs

Prednisolone Solution Needs Stability Studies: Petition

The drug development consulting firm Rahaa asks FDA to require stability studies under refrigerated conditions for generic versions of prednisolone op...

latest-news-card-1
Federal Register

Peripheral/CNS Drugs Panel Renewed

Federal Register notice: FDA renews for two years its Peripheral and Central Nervous System Drugs advisory committee.

latest-news-card-1
Biologics

Galderma BLA for Nemluvio Approved

FDA approves a Galderma BLA for Nemluvio (nemolizumab), a pre-filled pen for subcutaneous injection for adults with prurigo nodularis.

latest-news-card-1
Biologics

Objectionable Conditions in Doctors Clinical Trial

FDA warns Lublin, Poland, physician Konrad Rejdak about Bioresearch Monitoring violations in a clinical study for which he was the study director.

latest-news-card-1
Human Drugs

Nowrez & Ismail Shukri CGMP Violations

FDA warns Jordans Nowrez and Ismail Shukri Company about CGMP violations in the production of OTC drugs.

Medical Devices

QS, MDR Violations at Globus Medical

FDA warns Globus Medical about Quality System and Medical Device Reporting violations in its production of the Excelsius GPS surgical robot.

latest-news-card-1
Human Drugs

Proprietary Name Review MAPP

A CDER Manual of Policies and Procedures lists responsibilities for the Office of Surveillance and Epidemiology and other CDER offices dealing with th...

latest-news-card-1
Human Drugs

Tandem Diabetes Insulin Pump App Recall

Tandem Diabetes Care updates its March recall of its Apple iOS t:connect mobile app in the U.S. due to an issue that can cause rapid depletion of a us...

latest-news-card-1
Human Drugs

Creating Hope Reauthorization Act Introduced

Sen Susan Collins and a bipartisan group of her colleagues introduce the Creating Hope Reauthorization Act to extend until 2030 the FDA priority revie...

latest-news-card-1
Human Drugs

Change Biological Drug Monographs: Petition

A University of Illinois Chicago College of Pharmacy petition calls on FDA to authorize a new form of monograph for biological products.